POSTORINO, ELISA IMELDE
 Distribuzione geografica
Continente #
EU - Europa 537
NA - Nord America 476
AS - Asia 95
AF - Africa 3
OC - Oceania 2
SA - Sud America 1
Totale 1.114
Nazione #
US - Stati Uniti d'America 476
IE - Irlanda 155
IT - Italia 150
SE - Svezia 130
SG - Singapore 45
PL - Polonia 44
CN - Cina 42
DE - Germania 29
FI - Finlandia 7
FR - Francia 7
UA - Ucraina 6
EG - Egitto 3
IN - India 3
NL - Olanda 3
VN - Vietnam 3
NZ - Nuova Zelanda 2
AT - Austria 1
BR - Brasile 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
GB - Regno Unito 1
GR - Grecia 1
ID - Indonesia 1
MK - Macedonia 1
TH - Thailandia 1
Totale 1.114
Città #
Dublin 155
Chandler 115
Nyköping 74
Messina 63
Ashburn 45
Warsaw 44
Singapore 36
Dearborn 24
Boardman 20
Bremen 20
Princeton 20
Medford 19
Jacksonville 16
New York 16
Des Moines 12
Cambridge 11
Siracusa 11
Seattle 9
Ann Arbor 8
Zogno 8
Munich 7
Beijing 5
San Mateo 5
Tianjin 5
Carugate 4
Los Angeles 4
Nanjing 4
San Jose 4
Shenyang 4
Binasco 3
Dong Ket 3
Jiaxing 3
Ningbo 3
Norwalk 3
Palermo 3
Pune 3
Wilmington 3
Alzano Lombardo 2
Auckland 2
Bologna 2
Brescia 2
Haikou 2
Jinan 2
Padova 2
Ramacca 2
Rome 2
Torino 2
Zhengzhou 2
Amsterdam 1
Baltimore 1
Ban Kho 1
Brno 1
Brooklyn 1
Caltagirone 1
Catania 1
Changsha 1
Council Bluffs 1
Duncan 1
Enna 1
Hebei 1
Helsinki 1
Jakarta 1
João Pessoa 1
Kunming 1
Lago 1
Lancaster 1
Mascalucia 1
Milan 1
Milazzo 1
Mountain View 1
Nanchang 1
Nizza Monferrato 1
Piazza Armerina 1
Qingdao 1
Redwood City 1
Sacile 1
Shanghai 1
Siderno 1
Skopje 1
Taizhou 1
Viagrande 1
Vienna 1
Vittoria 1
Washington 1
Woodbridge 1
Totale 851
Nome #
Visual System Involvement in Patients with Newly Diagnosed Parkinson Disease 97
Use of homeopathic eye drops for the treatment of ocular surface irritation 94
Corneal Structural Changes in Nonneoplastic and Neoplastic Monoclonal Gammopathies 89
Combined Phialemonium curvatum and Acanthamoeba Keratitis, the Importance of Early Diagnosis and Specific Therapy 66
Efficacy of eyedrops containing cross-linked hyaluronic acid and coenzyme Q10 in treating patients with mild to moderate dry eye 62
Matrix Metalloproteinase 9 and Transglutaminase 2 Expression at the Ocular Surface in Patients with Different Forms of Dry Eye Disease 60
Effects of amino acids enriched tears substitutes on the cornea of patients with dysfunctional tear syndrome 54
Comparative Confocal and Histopathological Study of Corneal Changes in Multiple Myeloma 54
Early Corneal Innervation and Trigeminal Alterations in Parkinson Disease: A Pilot Study 53
Changes in conjunctival epithelial cells after treatment with 0.2% xanthan gum eye drops in mild-moderate dry eye 53
Tear film and ocular surface assessment in psoriasis 53
Esperienza con secukinumab in un paziente psoriasico con comorbilità oculare 51
The Role of Hi-Tech Devices in Assessment of Corneal Healing in Patients with Neurotrophic Keratopathy 50
Secukinumab for plaque psoriasis with ocular comorbidity: a clinical experience 46
Safety and efficacy of 0.1% clobetasone butyrate eye drops in the treatment of dry eye in Sjögren's syndrome patients 43
The role of innate immunity in dry eye syndrome 37
Post-surgical management of cataract: Light and dark in the 2020s 36
Clinical and instrumental assessment of the corneal healing in moderate and severe neurotrophic keratopathy treated with rh-NGF (Cenegermin) 33
Ophthalmologic Manifestations of Primary Sjögren’s Syndrome 31
Clinical Efficacy, Tolerability and Safety of a New Multiple-Action Eyedrop in Subjects with Moderate to Severe Dry Eye 29
Effects of the Topical Use of the Natural Antioxidant Alpha-Lipoic Acid on the Ocular Surface of Diabetic Patients with Dry Eye Symptoms 23
null 23
null 18
Effectiveness of a New Active Tear Substitute Containing 0.2% Hyaluronic Acid and 0.001% Hydrocortisone on Signs and Symptoms of Dry Eye Disease by Means of Low- and High-Tech Assessments 4
Use of allogeneic platelet-rich plasma for the treatment of autoimmune ocular surface disorders: case series 3
Observational Clinical Investigation Evaluating an Ophthalmic Solution Containing Xanthan Gum and Low Concentration Desonide Phosphate in Dry Eye Disease Treatment 3
Correction: Observational Clinical Investigation Evaluating an Ophthalmic Solution Containing Xanthan Gum and Low Concentration Desonide Phosphate in Dry Eye Disease Treatment 3
Totale 1.168
Categoria #
all - tutte 5.415
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.415


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202051 0 0 0 0 1 28 6 5 2 5 3 1
2020/2021195 10 10 25 6 31 5 8 18 25 50 2 5
2021/2022173 0 4 9 7 2 12 6 15 9 47 11 51
2022/2023439 27 55 17 27 40 39 6 32 177 1 15 3
2023/2024141 10 15 8 20 14 41 0 6 0 1 0 26
2024/202574 4 4 16 41 9 0 0 0 0 0 0 0
Totale 1.168